Puma Biotechnology, Inc. (NYSE: PBYI), a development stage
biopharmaceutical company, announced top line results from a Phase II
clinical trial of Puma's investigational drug PB272 (neratinib) for the
treatment of first-line HER2-positive locally recurrent or metastatic
breast cancer (NEfERTT trial). The NEfERTT trial is a randomized,
two-arm Phase II trial of neratinib plus the anticancer drug paclitaxel
versus trastuzumab (Herceptin) plus paclitaxel as a first-line treatment
for HER2- positive locally recurrent or metastatic breast cancer.
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced financial results for the
first quarter of fiscal year 2015, which ended September 30, 2014.
Following Temporary First Quarter Delays Anticipates Significant Pick Up in Project Completions in Subsequent Quarters Recon Technology Fiscal Year 2015 First Quarter Investor Conference Call Scheduled for Friday, November 14th at 8:00am EST
BEIJING , Nov.
Kingstone Companies, Inc. (Nasdaq:KINS) (the “Company” or
“Kingstone”), a multi-line regional property and casualty insurance
holding company, today announced its financial results for the third
quarter and nine months ended September 30, 2014.
CBL & Associates Properties, Inc. (NYSE: CBL) today announced that its
Board of Directors has declared an 8.2% increase in the quarterly cash
dividend for the Company’s Common Stock to $0.265 per share for the
quarter ending December 31, 2014.
Company to Hold Conference Call with Accompanying Slide Presentation on November 14, 2014, at 8:30 a.m ET Company Reiterates 2014 Guidance of Between 60 metric tons and 70 metric tons of Gold Processed During 2014
WUHAN, China , Nov.
Total revenue of $3.3 million for the second quarter Net loss of $718,000, reduced from $1.4 million in same period last year Oculus owns two million shares of Ruthigen (Nasdaq:RTGN) Net worth of $13.4 million, up $11.9 million from September 30, 2013 Conference Call Begins at 4:30 p.m. (ET) Today
PETALUMA, Calif., Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.